.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Accenture
Novartis
Baxter
Argus Health
Queensland Health
Cantor Fitzgerald
Chubb
US Army

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020688

« Back to Dashboard

NDA 020688 describes PATANOL, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from three suppliers. Additional details are available on the PATANOL profile page.

The generic ingredient in PATANOL is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.

Summary for 020688

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020688

Suppliers and Packaging for NDA: 020688

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PATANOL olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 020688 NDA Alcon Laboratories, Inc. 0065-0271 0065-0271-05 5 mL in 1 BOTTLE, PLASTIC (0065-0271-05)
PATANOL olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 020688 NDA A-S Medication Solutions 50090-0593 50090-0593-0 5 mL in 1 BOTTLE, PLASTIC (50090-0593-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.1% BASE
Approval Date:Dec 18, 1996TE:ATRLD:Yes

Expired Orange Book Patents for NDA: 020688

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms CorpPATANOLolopatadine hydrochlorideSOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 1996► Subscribe► Subscribe
Novartis Pharms CorpPATANOLolopatadine hydrochlorideSOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 1996► Subscribe► Subscribe
Novartis Pharms CorpPATANOLolopatadine hydrochlorideSOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 1996► Subscribe► Subscribe
Novartis Pharms CorpPATANOLolopatadine hydrochlorideSOLUTION/DROPS;OPHTHALMIC020688-001Dec 18, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Novartis
Teva
Julphar
Cantor Fitzgerald
McKinsey
Baxter
Covington
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot